KERI ASRAF, OD
8230 W SAHARA AVE STE 121, LAS VEGAS, NV 89117
NPI Number
1003437955
Practice location · View on Google Maps
Total Medicaid Payments
$143,138
-21% vs specialty average
Patients Seen
6,253
Total Claims
6,471
$ Per Patient
$23
Specialty avg: $38
Specialty Rank
#96 of 377
Optometrist providers in Nevada
Peer Average
$181,896
Average total for Optometrist
Claims per Patient
1.0
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2021 | $14,484 | |
| 2022 | $38,738 | |
| 2023 | $34,778 | |
| 2024 | $55,139 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| V2025 | Deluxe frame | 1,219 | $58,850 | 41.1% | $48 |
| 92014 | Eye exam or vision test | 479 | $22,302 | 15.6% | $47 |
| 92340 | Eye exam or vision test | 1,422 | $21,495 | 15.0% | $15 |
| 92004 | Eye exam or vision test | 336 | $15,933 | 11.1% | $47 |
| V2020 | Frames, purchases | 451 | $12,064 | 8.4% | $27 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 528 | $8,185 | 5.7% | $16 |
| 92015 | Eye exam or vision test | 595 | $3,019 | 2.1% | $5 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 796 | $900 | 0.6% | $1 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 633 | $392 | 0.3% | $1 |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 12 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.